Howard R. Soule, Ph.D., to Retire as Chief Science Officer of the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) today announced that Howard R. Soule, Ph.D., will retire as PCF’s Chief Science Officer, Executive Vice President, and Lori and Michael Milken Chair at the end of March 2026. For nearly three decades, Dr. Soule’s visionary leadership of PCF’s prestigious and high-impact programs to advance prostate cancer research and treatments has helped improve and extend the lives of countless patients with prostate cancer, helping drive the work behind 14 new life-extending therapies and paving the way for many promising new avenues of clinical investigation.
The Prostate Cancer Foundation Debuts Refreshed Website, Creating Enhanced Resource for Patients, Physicians, Researchers, Caregivers and Donors
The Prostate Cancer Foundation (PCF) announced the launch of its new website, offering a highly-tailored platform that connects visitors to trusted information and resources on prostate cancer diagnosis, treatments, science and fundraising initiatives designed to improve patients’ lives, accelerate research and advance medical breakthroughs. The website reflects PCF’s position as world’s leading philanthropic organization dedicated to funding prostate cancer research and the authoritative source for prostate cancer information.
The Prostate Cancer Foundation Appoints Phillip Koo, M.D., as Chief Medical Officer
The Prostate Cancer Foundation (PCF) today announced the appointment of Phillip Koo, M.D., as chief medical officer. Dr. Koo will lead PCF’s patient navigation programs, help increase understanding and reduction of critical patient care gaps, and accelerate novel programs designed to fulfill PCF’s mission of ending death and suffering from prostate cancer.
